These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16404633)

  • 21. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of impartial assessment of geriatric brain diseases].
    Spiegel R
    Ther Umsch; 1997 Jun; 54(6):314-20. PubMed ID: 9289868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of Montreal Cognitive Assessment in the Fifth Edition of Diagnostic and Statistical Manual of Mental Disorders: major and mild neurocognitive disorders.
    Liew TM; Feng L; Gao Q; Ng TP; Yap P
    J Am Med Dir Assoc; 2015 Feb; 16(2):144-8. PubMed ID: 25282632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric properties and factor structure of an expanded CERAD neuropsychological battery in an elderly VA sample.
    Jones SN; Ayers CR
    Arch Clin Neuropsychol; 2006 May; 21(4):359-65. PubMed ID: 16766158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine.
    Savaskan E; Schnitzler C; Schröder C; Cajochen C; Müller-Spahn F; Wirz-Justice A
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):507-16. PubMed ID: 16316485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A total score for the CERAD neuropsychological battery.
    Chandler MJ; Lacritz LH; Hynan LS; Barnard HD; Allen G; Deschner M; Weiner MF; Cullum CM
    Neurology; 2005 Jul; 65(1):102-6. PubMed ID: 16009893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia.
    Fillenbaum GG; McCurry SM; Kuchibhatla M; Masaki KH; Borenstein AR; Foley DJ; Heyman A; Larson EB; White L
    J Int Neuropsychol Soc; 2005 Mar; 11(2):192-201. PubMed ID: 15966108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detailed analysis of the Japanese version of the Rapid Dementia Screening Test using Arabic-hiragana conversion.
    Moriyama Y; Yoshino A; Muramatsu T; Mimura M
    Psychogeriatrics; 2018 Nov; 18(6):446-450. PubMed ID: 30058752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of symptoms on the CERAD behavior rating scale for dementia in normal elderly subjects and Alzheimer's disease patients.
    Tractenberg RE; Patterson M; Weiner MF; Teri L; Grundman M; Thomas RG; Thal LJ
    J Neuropsychiatry Clin Neurosci; 2000; 12(4):472-9. PubMed ID: 11083164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translation of clinical and neuropsychological instruments into French: the CERAD experience.
    Demers P; Robillard A; Laflèche G; Nash F; Heyman A; Fillenbaum G
    Age Ageing; 1994 Nov; 23(6):449-51. PubMed ID: 9231936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Clock Drawing Test for dementia of the Alzheimer's type: A comparison of three scoring methods in a memory disorders clinic.
    Brodaty H; Moore CM
    Int J Geriatr Psychiatry; 1997 Jun; 12(6):619-27. PubMed ID: 9215942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Mini-Cog versus the Mini-Mental State Examination and the Clock Drawing Test in daily clinical practice: screening value in a German Memory Clinic.
    Milian M; Leiherr AM; Straten G; Müller S; Leyhe T; Eschweiler GW
    Int Psychogeriatr; 2012 May; 24(5):766-74. PubMed ID: 22172089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mini-Addenbrooke's Cognitive Examination: a pragmatic diagnostic accuracy study.
    Larner AJ
    Int J Geriatr Psychiatry; 2015 May; 30(5):547-8. PubMed ID: 25855207
    [No Abstract]   [Full Text] [Related]  

  • 36. Questionable dementia: clinical course and predictors of outcome.
    Devanand DP; Folz M; Gorlyn M; Moeller JR; Stern Y
    J Am Geriatr Soc; 1997 Mar; 45(3):321-8. PubMed ID: 9063278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive decline in the behavioral variant of frontotemporal dementia.
    Diehl-Schmid J; Bornschein S; Pohl C; Förstl H; Kurz A; Jahn T
    Int Psychogeriatr; 2011 Mar; 23(2):230-7. PubMed ID: 20836915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age-, sex-, and education-specific norms for an extended CERAD Neuropsychological Assessment Battery-Results from the population-based LIFE-Adult-Study.
    Luck T; Pabst A; Rodriguez FS; Schroeter ML; Witte V; Hinz A; Mehnert A; Engel C; Loeffler M; Thiery J; Villringer A; Riedel-Heller SG
    Neuropsychology; 2018 May; 32(4):461-475. PubMed ID: 29517259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the best dementia screening instrument for general practitioners to use?
    Brodaty H; Low LF; Gibson L; Burns K
    Am J Geriatr Psychiatry; 2006 May; 14(5):391-400. PubMed ID: 16670243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory testing in dementia: how much is enough?
    Derrer DS; Howieson DB; Mueller EA; Camicioli RM; Sexton G; Kaye JA
    J Geriatr Psychiatry Neurol; 2001; 14(1):1-6. PubMed ID: 11281309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.